GSK sponsors World Hepatitis Testing Week to raise awareness

This #WorldHepatitisTestingWeek, hosted by the World Hepatitis Alliance, we’re shining a spotlight on the critical importance of testing for hepatitis B. Hepatitis B remains a major global health challenge, affecting over 254 million people worldwide and potentially leading to serious complications such as liver damage and cancer. Yet, many people living with hepatitis B are unaware of their condition, as symptoms often go unnoticed. We are proud to sponsor World Hepatitis Testing Week, introduced in response to the lack of progress in testing which remains one of the biggest barriers to meeting the WHO goal of eliminating viral hepatitis as a public health threat by 2030. At GSK, we recognise that timely and accurate testing is essential to support earlier diagnosis– a vital step toward reducing the long term impact of the disease. By raising visibility this week, we aim to build understanding of the importance of testing and encourage more conversations about early diagnosis and care for people living with hepatitis B.